Eprosartan

From WikiMD's WELLNESSPEDIA

(Redirected from Eprosartan mesylate)

Overview of the antihypertensive drug Eprosartan

Eprosartan

Eprosartan






























Eprosartan is an angiotensin II receptor antagonist used primarily for the treatment of hypertension. It is part of the class of medications known as angiotensin receptor blockers (ARBs), which work by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict.

Pharmacology[edit]

Eprosartan functions by selectively blocking the binding of angiotensin II to the angiotensin II receptor type 1 (AT1 receptor) in various tissues, including vascular smooth muscle and the adrenal gland. This action leads to vasodilation and a reduction in blood pressure.

Mechanism of Action[edit]

Structural formula of Eprosartan

Eprosartan inhibits the effects of angiotensin II by preventing its binding to the AT1 receptor. Angiotensin II is a potent vasoconstrictor and a key component of the renin-angiotensin system, which regulates blood pressure and fluid balance. By blocking this pathway, eprosartan reduces peripheral vascular resistance and lowers blood pressure.

Pharmacokinetics[edit]

Eprosartan is administered orally and is absorbed through the gastrointestinal tract. It has a bioavailability of approximately 13% and reaches peak plasma concentrations within 1 to 2 hours after ingestion. The drug is primarily excreted unchanged in the urine and feces.

Clinical Use[edit]

Eprosartan is indicated for the management of hypertension. It may be used alone or in combination with other antihypertensive agents, such as diuretics or calcium channel blockers.

Dosage and Administration[edit]

The typical starting dose of eprosartan is 600 mg once daily. The dose may be adjusted based on the patient's response and clinical condition. It is important to monitor blood pressure regularly to ensure optimal control.

Side Effects[edit]

Common side effects of eprosartan include dizziness, headache, and fatigue. These effects are generally mild and transient. Serious adverse effects are rare but may include angioedema and renal impairment.

Contraindications[edit]

Eprosartan is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should not be used during pregnancy due to the risk of fetal harm.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Eprosartan&oldid=6291759"